Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,362 public trials 335 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Recruiting

Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)

NCT07079475

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Chest Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Harbin Cancer Hospital Harbin, Heilongjiang, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 16 locations
View Trial Details
Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NCT06881784

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
  • Yale University, Smillow Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute - South Fort Myers, Florida, United States
View all 153 locations
View Trial Details
Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT06350097

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Fountain Valley, California, United States
  • Research Site Los Alamitos, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 167 locations
View Trial Details
Recruiting

A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression

NCT07412262

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China Guangzhou, Guangdong, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
View Trial Details
Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

NCT06765109

Conditions
Anaplastic Lymphoma Kinase-positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Hoag Hospital Newport Beach Newport Beach, California, United States
  • University of California, Irvine Health Orange, California, United States
  • Rocky Mountain Cancer Centers Boulder, Colorado, United States
View all 158 locations
View Trial Details
Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

NCT05899608

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner University Medical Center Phoenix, Arizona, United States
  • TMC Healthcare Tucson, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
  • University of Arkansas Little Rock, Arkansas, United States
View all 260 locations
View Trial Details
Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

NCT06586515

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 52 locations
View Trial Details
Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

NCT06774963

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Biliary Tract Cancer, +37 more
Locations
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University, Siteman Cancer Center St Louis, Missouri, United States
View all 14 locations
View Trial Details

Related conditions